Trial · NCT06179290
Registered outcomes14
Each outcome the trial registered, primary first, in ClinicalTrials.gov's words.
1 to 14 of 14
Download this page as JSON| List | Outcome | Time frame | Description |
|---|---|---|---|
| Primary | Total 4-(Methylnitrosamino)-1-(3-pyridyl)-1-butanol (NNAL) | Baseline through Day 5 | Total 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanol (NNAL) in urine adjusted for urine creatinine (pg/mg creatinine) |
| Primary | Total N-nitrosonornicotine (NNN) | Baseline through Day 5 | Total N-nitrosonornicotine (NNN) in urine adjusted for urine creatinine (pg/mg creatinine) |
| Primary | 2-hydroxybutenylmercapturic Acid (2-MHBMA) | Baseline through Day 5 | 2-hydroxybutenylmercapturic acid (2-MHBMA) in urine adjusted for urine creatinine (ng/mg creatinine) |
| Primary | 3-hydroxypropylmercapturic Acid (3-HPMA) | Baseline through Day 5 | 3-hydroxypropylmercapturic acid (3-HPMA) in urine adjusted for urine creatinine (ng/mg creatinine) |
| Primary | S-phenyl Mercapturic Acid (SPMA) | Baseline through Day 5 | S-phenyl mercapturic acid (SPMA) in urine adjusted for urine creatinine (pg/mg creatinine) |
| Primary | 2-Hydroxyethyl Mercapturic Acid (HEMA) | Baseline through Day 5 | 2-Hydroxyethyl mercapturic acid (HEMA) in urine adjusted for urine creatinine (ng/mg creatinine) |
| Primary | 1-aminonaphthalene (1-AN) | Baseline through Day 5 | 1-aminonaphthalene (1-AN) in urine adjusted for urine creatinine (pg/mg creatinine) |
| Primary | 2-aminonaphthalene (2-AN) | Baseline through Day 5 | 2-aminonaphthalene (2-AN) in urine adjusted for urine creatinine (pg/mg creatinine) |
| Primary | 2-cyanoethyl-mercapturic Acid (CEMA) | Baseline to Day 5 | 2-cyanoethyl-mercapturic acid (CEMA) in urine adjusted for urine creatinine (ng/mg creatinine) |
| Primary | 3-hydroxybenzo[a]Pyrene (3-OH-B[a]P) | Baseline through Day 5 | 3-hydroxybenzo\[a\]pyrene (3-OH-B\[a\]P) in urine adjusted for urine creatinine (fg/mg creatinine) |
| Primary | 3-hydroxy-1-methylpropylmercapturic Acid (HMPMA) | Baseline through Day 5 | 3-hydroxy-1-methylpropylmercapturic acid (HMPMA) in urine adjusted for urine creatinine (ng/mg creatinine) |
| Primary | 4-Aminobiphenyl (4-ABP) | Baseline through Day 5 | 4-Aminobiphenyl (4-ABP) in urine adjusted for urine creatinine (pg/mg creatinine) |
| Primary | S-benzyl Mercapturic Acid (SBMA) | Baseline through Day 5 | S-benzyl mercapturic acid (SBMA) in urine adjusted for urine creatinine (pg/mg creatinine) |
| Primary | Carboxyhemoglobin (COHb) | Baseline to Day 5 | COHb, or carboxyhemoglobin, is the percent of hemoglobin that is bound to carbon monoxide instead of oxygen |
Source ClinicalTrials.govtrials-2026-11-12-0.5.0
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/trials/v1/NCT06179290/registered